Sullivan Lynne Marie
CFO & Head of Corp. Dev. at Unity Biotechnology, Inc.
- Sold, on record
- $24k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Apr 2, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Unity Biotechnology, Inc.CFO & Head of Corp. Dev.
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Unity Biotechnology, Inc.No planJun 25, 2024 2024
Sold 324 shares at $1.40 ($454)
Sullivan Lynne Marie, CFO & Head of Corp. Dev.
No 10b5-1 planSold 1% of holdings ($46k position)32,685 shares leftFirst sale on recordFiling
- 2 Form 4 sale Unity Biotechnology, Inc.No planAug 2, 2024 +38 days
Sold 139 shares at $1.53 ($213)
Sullivan Lynne Marie, CFO & Head of Corp. Dev.
No 10b5-1 planSold 0.2% of holdings ($86k position)56,061 shares leftFiling
- 3 Form 4 sale Unity Biotechnology, Inc.No planNov 4, 2024 +94 days
Sold 136 shares at $1.29 ($175)
Sullivan Lynne Marie, CFO & Head of Corp. Dev.
No 10b5-1 planSold 0.2% of holdings ($72k position)55,925 shares leftFiling
- 4 Form 4 sale Unity Biotechnology, Inc.No planFeb 4, 2025 +92 days
Sold 153 shares at $2.23 ($341)
Sullivan Lynne Marie, CFO & Head of Corp. Dev.
No 10b5-1 planSold 0.3% of holdings ($125k position)55,772 shares left1.1x usual sizeFiling
- 5 Form 4 sale Unity Biotechnology, Inc.UnusualApr 2, 2025 +57 days
Sold 21,867 shares at $1.03 ($23k)
Sullivan Lynne Marie, CFO & Head of Corp. Dev.
No 10b5-1 planSold 18.1% of holdings ($124k position)98,905 shares left149.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Apr 3, 2025 | Unity Biotechnology, Inc. | CFO & Head of Corp. Dev. | Form 4 sale | 21,867 | $23k | 18.1% | Unusual | SEC |
| Feb 4, 2025 | Feb 5, 2025 | Unity Biotechnology, Inc. | CFO & Head of Corp. Dev. | Form 4 sale | 153 | $341 | 0.3% | No plan | SEC |
| Nov 4, 2024 | Nov 6, 2024 | Unity Biotechnology, Inc. | CFO & Head of Corp. Dev. | Form 4 sale | 136 | $175 | 0.2% | No plan | SEC |
| Aug 2, 2024 | Aug 6, 2024 | Unity Biotechnology, Inc. | CFO & Head of Corp. Dev. | Form 4 sale | 139 | $213 | 0.2% | No plan | SEC |
| Jun 25, 2024 | Jun 26, 2024 | Unity Biotechnology, Inc. | CFO & Head of Corp. Dev. | Form 4 sale | 324 | $454 | 1.0% | No plan | SEC |